Clinical Trial Update: Carcinogenicity Study of Bupropion

View source ↗

Summary

Completed carcinogenicity study of bupropion with results posted by sponsor GlaxoSmithKline, involving depressive disorder and cancer as conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Depressive Disorder

Drugs mentioned

• bupropion (bupropion)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Depressive Disorder, Cancer | Status: COMPLETED | Results posted: 2011-02-10